Ensign Peak Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $509K | Hold |
|
|||||
|
2025
Q1 | $643K | Sell |
|
|||||
|
2024
Q4 | $2.52M | Sell |
|
|||||
|
2024
Q3 | $2.34M | Sell |
|
|||||
|
2024
Q2 | $3.18M | Sell |
|
|||||
|
2024
Q1 | $15.3M | Buy |
|
|||||
|
2023
Q4 | $14.7M | Buy |
|
|||||
|
2023
Q3 | $7.06M | Buy |
|
|||||
|
2023
Q2 | $2.81M | Buy |
|
|||||
|
2023
Q1 | $1.97M | Sell |
|
|||||
|
2022
Q4 | $8.45M | Buy |
|
|||||
|
2022
Q3 | $1.52M | Sell |
|
|||||
|
2022
Q2 | $6.34M | Buy |
|
|||||
|
2022
Q1 | $2.04M | Sell |
|
|||||
|
2021
Q4 | $4.05M | Buy |
|
|||||
|
2021
Q3 | $97K | Sell |
|
|||||
|
2021
Q2 | $2.96M | Buy |
|
|||||
|
2021
Q1 | $1.83M | Hold |
|
|||||
|
2020
Q4 | $2.44M | Buy |
|
|||||
|
2020
Q3 | $1.06M | Buy |
|
|||||
|
2020
Q2 | $802K | Buy |
|
|||||
|
2020
Q1 | $206K | Sell |
|
|||||
|
2019
Q4 | $314K | Buy |
|